GlassScriptPhysician profile
Joseph A Cipriano
NPI 1346295979
$362.46
in general payments reported to CMS, 2019-2025
10 companies · $18.29 in 2025
The $18.29 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $168 · 2020: $105 · 2022: $14.44 · 2023: $22.40 · 2024: $35.10 · 2025: $18.29.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $75.79.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $75.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $173.47 | 2019-2020 | |
| Viiv Healthcare Company | $56.24 | 2023-2025 | Cabenuva |
| Daiichi Sankyo INC. | $26.12 | 2019 | |
| Lilly USA, LLC | $19.55 | 2024 | Zepbound |
| Aspira Women'S Health INC | $19.19 | 2020 | |
| Astellas Pharma US INC | $14.47 | 2019 | |
| Evofem Biosciences, INC. | $14.44 | 2022 | |
| Radius Health, INC. | $14.35 | 2019 | |
| Merck Sharp & Dohme LLC | $13.36 | 2019 | |
| Exeltis, USA INC. | $11.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Cipriano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.